Psoríase Online
■ Diagnosis and management of psoriasis
Whan B. Kim, Dana Jerome, Jensen Yeung
Can Fam Physician. 2017 Apr; 63(4): 278–285.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5389757/
■ Psoriasis and psoriatic arthritis
Jennifer Clay Cather, Melodie Young, Martin Jan Bergman
J Clin Aesthet Dermatol. 2017 Mar; 10(3): S16–S25
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5367866/
■ Psoriasis comorbidities: complications and benefits of immunobiological treatment
Carvalho, André Vicente Esteves de et al.
An. Bras. Dermatol., Dec 2016, vol.91, no.6, p.781-789
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962016000600781&lng=pt&nrm=iso
■ Systemic abnormalities of psoriatic patients: a retrospective study
L Yin, J L Xu, A Johnston, Z Q Yin
Clinical, Cosmetic and Investigational Dermatology 2016, vol 9: 443-449
■ Dietary behaviors in psoriasis: patient-reported outcomes from a U.S.National Survey
Dermatol Ther (Heidelb) 2017 Jun; 7(2): 227–24
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5453925/
■ Vitamin D and its role in psoriasis: an overview of the dermatologist and nutritionist
Luigi Barrea, Maria Cristina Savanelli, Carolina Di Somma, Maddalena Napolitano,
Rev Endocr Metab Disord. 2017; vol 18(2): 195–205
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5486909/
■ Psoriasis and atopic dermatitis
Christopher E. M. Griffiths, Peter van de Kerkhof, Magdalena Czarnecka-Operacz
Dermatol Ther (Heidelb) 2017 Jan; 7(Suppl 1): 31–41
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5289118/
■ How does stigma affect people with psoriasis?
Patryk Łakuta, Kamil Marcinkiewicz, Beata Bergler-Czop, Ligia Brzezińska-Wcisło
Postepy Dermatol Alergol. 2017 Feb; 34(1): 36–41.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5329101/
■ Neurodegenerative disorders, bullos pemhigoid and psoriasis: a comparative study in ethnic Poles indicate that Parkinson´s disease is more relevant to bullos pemphigoid
Paweł Bartkiewicz, Justyna Gornowicz-Porowska, Paweł P. Pietkiewicz et al
Postepy Dermatol Alergol. 2017 Feb; 34(1): 42–46
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5329105/
■ Under-treatment of patients with moderate to severe psoriasis in the United States: analysis of medication usage with health plan data
April W. Armstrong, J. Will Koning, Simon Rowse et al
Dermatol Ther (Heidelb) 2017 Mar; 7(1): 97–109
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5336424/
■ Cognitive impairment in patients with severe psoriasis
Luiza Marek-Józefowicz, Marcin Jaracz, Waldemar Placek et al
Postepy Dermatol Alergol. 2017 Apr; 34(2): 120–125
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5420603/
■ Prevalencia de la enfermedad celíaca en los pacientes con psoriasis
C Rafaelli, N Poggio, V Neglia et al
Dermatologia Argentina 2017, vol 23 (1): 23-28
http://www.dermatolarg.org.ar/index.php/dermatolarg/article/view/1563/895
■ Clinical evaluation of omega-3 fatty acids in psoriasis
M Adil, P K Singh, K Maheshwari
Dermatol Rev/Przegl Dermatol 2017, vol 104:314-323
https://www.termedia.pl/Clinical-evaluation-of-omega-3-fatty-acids-in-psoriasis,56,30259,1,1.html
■ Psoriasis, psoriatic arthritis, and thyroid autoimmunity
Ruffilli I, Ragusa F, Benvenga S, Vita R, Antonelli A, Fallahi P, Ferrari SM.
Front Endocrinol (Lausanne). 2017 , vol 8:13
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5474675/
■ Quantitative evaluation of biologic therapy options for psoriasis: a systematic review and network meta-analysis
Zarif K. Jabbar-Lopez, Zenas Z.N. Yiu, Victoria Ward et al
J Invest Dermatol. 2017, vol 137(8): 1646–1654
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5519491/
■ Impact of biologic therapies on risk of major adverse cardiovascular events in patients with psoriasis: systematic review and meta-analysis of randomized controlled trials
- Rungapiromnan, Z.Z.N. Yiu, R.B. Warren, C.E.M. Griffiths, D.M. Ashcroft
Br J Dermatol. 2017 vol 176(4): 890–901
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5412670/
■ Monitoring treatment response in psoriasis: current perspectives on the clinical utility of reflectance confocal microscopy
M Agozzino, C Noal, F Lacarruba, M Ardigó
Psoriasis: Targets and Therapy 2016, vol 6: 27-34
■ Local effects of adipose tissue in psoriasis and psoriatic arthritis
I L Kruglikov, U Wollina
Psoriasis: Targets and Therapy 2016, vol 6: 17-25
■ Current knowledge on psoriasis and autoimmune diseases
N Ayala-Fontánez, D C Soler, T S McCormick
Psoriasis: Targets and Therapy 2016, vol 6: 7-32
■ Excimer laser for the treatment of psoriasis: safety, efficacy and patient acceptability
M Abrouk, E Levin, M Brodsky et al
Psoriasis: Targets and Therapy 2016, vol 6: 165-173
■ Tacrolimus for the management of psoriasis: clinical utility and place in therapy
N Malecic, H Young
Psoriasis: Targets and Therapy 2016, vol 6: 153-163
■ Pustular psoriasis: pathophysiology and current treatment perspectives
K E Benjegerdes, K Hyde, D Kivelevitch, B Mansouri
Psoriasis: Targets and Therapy 2016, vol 6: 131-163
■ Hepatitis B reactivation in psoriasis patients treated with anti-TNF agents: prevention and management
M V Cannizzaro, C Franceschini, M Esposito et AL
Psoriasis: Targets and Therapy 2016, vol 6: 35-40
■ Herpes zoster in psoriasis patients undergoing treatment with biological agents: prevalence, impact, and management challenges
L el Hayderi, F Colson, B Dezfoulian, A F Nikkels
Psoriasis: Targets and Therapy 2016, vol 6: 145-151
■ Prevalence of acute and chronic viral seropositivity and characteristics of disease in patients with psoriatic arthritis treated with cyclosporine: a post hoc analysis from a sex point of view on the observational study of infections events in psoriasis complicated by active psoriatic arthritis
D Colombo, S Chimenti, P A Grossi et al
Clinical, Cosmetic and Investigational Dermatology 2016, vol 9: 1-7
■ Oral fumaric acid esters for psoriasis: abridged Cochrane systematic review incluind GRADE assessment
A Atwan, J R Ingram, R Abbot et AL
British Journal of Dermatology 2016, vol 175 (5): 83-881
http://onlinelibrary.wiley.com/doi/10.1111/bjd.14676/full
■ Psoriasis in children
R Pinson, B Sotoodian, L Fiorillo
Psoriasis: Targets and Therapy 2016, vol 6: 121-129
https://www.dovepress.com/psoriasis-in-children-peer-reviewed-fulltext-article-PTT
■ Combining biologic and phototherapy for psoriasis: safety, efficacy, and patient acceptability
B Farahnik, V Patel, K Berokhim et al
Psoriasis: Targets and Therapy 2016, vol 6: 105-111
■ Erythordermic psoriasis: pathophysiology and current treatment perspectives
R K Sing, K M Lee, D Ucmark et al
Psoriasis: Targets and Therapy 2016, vol 6: 93-10
■ Psoriasis and inflammatory bowel disease: links and risks
C Vlachos, G Gaitanis, K H Katsanos et AL
Psoriasis: Targets and Therapy 2016, vol 6: 73-92
■ Psoriasis and smoking: links and risks
L Naldi
Psoriasis: Targets and Therapy 2016, vol 6: 65-71
https://www.dovepress.com/psoriasis-and-smoking-links-and-risks-peer-reviewed-fulltext-article-PTT
■ Improving access to home phototherapy for patients with psoriasis: current challenges and future prospects
S M Franken, C L Vierstra, T Rstemeyer
Psoriasis: Targets and Therapy 2016, vol 6: 55-64
■ Assessment and monitoring of biologic drug adverse events in patients with psoriasis
T Hanley, M Handford, D Lavery, Z Z N Yiu
Psoriasis: Targets and Therapy 2016, vol 6: 41-54
■ Management of scalp psoriasis: current perspectives
K Blakely, M Gooderham
Psoriasis: Targets and Therapy 2016, vol 6: 33-40
■ Integrating lifestyle-focused approaches into psoriasis care: improving patient outcomes?
A Landriscina, A J Friedman
Psoriasis: Targets and Therapy 2016, vol 6: 1-5
■ The psychosocial impact of acne, vitiligo, and psoriasis: a review
C M Nguyen, K Beroukhim, M J Danesh et al
Clinical, Cosmetic and Investigational Dermatology 2016, vol 9: 383-392
■ New oral therapies for psoriasis: a comprehensive review
Gary Goldenberg, Julien Lanoue, Joanna Dong
J Clin Aesthet Dermatol. 2016 Aug; 9(8): 25–28
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5022993/
■ Psoriasis and associated psychiatric disorders: a systematic review on etiopathogenesis and clinical correlation
Bárbara Isabel Roque Cunha Ferreira, José Luís Pio Da Costa Abreu, José Pedro Gaspar Dos Reis, Américo Manuel Da Costa Figueiredo
J Clin Aesthet Dermatol. 2016 Jun; 9(6): 36–43
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4928455/
■ Updates on psoriasis and cutaneos oncology: proceedings from the 2016 MaiDerm Meeting based on presentations by
George Martin, Bruce E. Strober, Craig L. Leonardi, Joel M. Gelfand, Andrew Blauvelt, Arthur Kavanaugh, Linda Stein Gold, Brian Berman, Ted Rosen, Eggert Stockfleth
J Clin Aesthet Dermatol. 2016 Sep; 9(9 Suppl 1): S5–S29
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5077303/
■ Oral apremilast for the treatment of plaque psoriasis
James Q. Del Rosso, Leon Kircik
J Clin Aesthet Dermatol. 2016 Sep; 9(9): 43–48
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5110328/
■ Study of serum levels and skin expression of S100B protein in psoriasis.
Salem, Samar Abdallah M. et al.
An. Bras. Dermatol., June 2017, vol.92, no.3, p.323-328
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962017000300323&lng=pt&nrm=iso
■ Paradoxical psoriasis after the use of anti-TNF in a patient with rheumatoid arthritis
Vasconcellos, Jaqueline Barbeito de et al.
An. Bras. Dermatol., Oct 2016, vol.91, no.5, suppl.1, p.137-139
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962016001100137&lng=pt&nrm=iso
■ Comparative microscopic analysis of nail clippings from patients with cutaneous psoriasis and psoriatic arthritis
Fonseca, Gabriela Poglia et al.
An. Bras. Dermatol., Feb 2017, vol.92, no.1, p.21-25
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962017000100021&lng=pt&nrm=iso
■ Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based cross-sectional study
Milčić, Danijela et al.
An. Bras. Dermatol., Feb 2017, vol.92, no.1, p.46-51
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962017000100046&lng=pt&nrm=iso
■ Relationship of Helicobacter pylori seroprevalence with the occurrence and severity of psoriasis
Mesquita, Priscila Miranda Diogo et al.
An. Bras. Dermatol., Feb 2017, vol.92, no.1, p.52-57
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962017000100052&lng=pt&nrm=iso
■ The role of intradermal proliferation of T-cells in the pathogenesis of psoriasis
Khairutdinov, Vladislav R. et al.
An. Bras. Dermatol., Feb 2017, vol.92, no.1, p.41-44
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962017000100041&lng=pt&nrm=iso
■ Chronic tophaceous gout in patients with psoriasis
Lobato, Laís Cruz et al.
An. Bras. Dermatol., Feb 2017, vol.92, no.1, p.104-106
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962017000100104&lng=pt&nrm=iso
■ Diagnosis and underdiagnosis of comorbidities in psoriasis patients – need for a multidisciplinary approach
Duarte, Gleison Vieira et al.
An. Bras. Dermatol., Dec 2016, vol.91, no.6, p.743-747
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962016000600743&lng=pt&nrm=iso
■ Treatment challenges in the management of moderate-to-severe plaque psoriasis – role of seckinmab
M Malakouti, S E Jacob, N J Anderson
Clinical, Cosmetic and Investigational Dermatology 2016, vol 9: 347-355
■ La genetic de la psoríasis
M R Herraiz, J J P Rodríguez
Med Cutan Iber Lat Am 2016, vol 44 (3): 159-166